Ā Cardiologist/Postdoctoral Fellow at Guangdong Provincial Peopleās Hospital, China
A dedicated cardiologist and postdoctoral fellow, with an impressive academic and clinical background across top global institutions, excelling in cardiovascular research and patient care. š Trained as an M.D. in China, later advancing to an M.S. in Guangdong, and completing a Ph.D. in the Netherlands with an exchange at Karolinska Institutet, Sweden. š Fluent in multiple languages, this versatile scholar contributes to cutting-edge cardiovascular knowledge, marked by significant accolades and grants. š Currently based at Guangdong Provincial Peopleās Hospital, they bring a global perspective to clinical cardiology, grounded in a decade of rigorous academic training and hands-on experience.
Publication Profile
orcid
Educationš
M.D. from Chongqing Medical University, China (2008ā2013). M.S. in Medical Sciences from Shantou University Medical College, Guangdong, China (2014ā2017). Ph.D. from University Medical Center Groningen, Netherlands (2017ā2022). Exchange Ph.D. at Karolinska Institutet, Sweden (2019ā2022).
Experience šØāāļø
Cardiologist/Postdoctoral Fellow, Cardiology Department, Guangdong Provincial Peopleās Hospital (2022āPresent). Medical Intern, First Affiliated Hospital of Shantou University Medical College (2016ā2017).
Awards and Honors š
Four-year full-time scholarship, China Scholarship Council. Overseas postdoctoral fellowship fundings. Notable conference presenter at ISCOMS (2017), AMGRO (2019), SSAR (2019, 2021), EAS (2020), CVP/CVR/THK/AC (2020), and ESC Congress (2024).
Research Focus š¬
Cardiovascular disease mechanisms and clinical interventions. Research on cardiac biomarkers, heart failure, and patient-centered care approaches. Ā International collaborations on advanced cardiology methods and findings in Europe and Asia.
“Exploring the potential of large language models in identifying metabolic dysfunctionāassociated steatotic liver disease: A comparative study of nonāinvasive tests and artificial intelligenceāgenerated responses,” Liver International, 2024-11-11, DOI: 10.1111/liv.16112.
Authors: Wanying Wu, Yuhu Guo, Qi Li, Congzhuo Jia.
2. “Impact of Platelet-to-HDL-Cholesterol Ratio on Long-Term Mortality in Coronary Artery Disease Patients with or Without Type 2 Diabetes: Insights from a Chinese Multicenter Cohort,” Journal of Inflammation Research, 2024-05, DOI: 10.2147/JIR.S458950.
Authors: Wanying Wu, Congzhuo Jia, Xiayan Xu, Yibo He, Yun Xie, Yang Zhou, Hongyu Lu, Jin Liu, Jiyan Chen, Yong Liu.
3. “Fibrinogen to HDL-Cholesterol ratio as a predictor of mortality risk in patients with acute myocardial infarction,” Lipids in Health and Disease, 2024-03-25, DOI: 10.1186/s12944-024-02071-7.
Authors: Congzhuo Jia, Wanying Wu, Huan Lu, Jin Liu, Shiqun Chen, Guoxiao Liang, Yang Zhou, Sijia Yu, Linfang Qiao, Jinming Chen.
4. “Comparison of cardiac biomarkers on risk assessment of contrastāassociated acute kidney injury in patients undergoing cardiac catheterization: A multicenter retrospective study,” Nephrology, 2023-11, DOI: 10.1111/nep.14233.
Authors: Sijia Yu, Qiang Li, Yibo He, Congzhuo Jia, Guoxiao Liang, Hongyu Lu, Wanying Wu, Jin Liu, Yong Liu, Jiyan Chen.
5. “Proportion and number of incident cancer deaths in coronary artery disease,” Cancer Medicine, 2023-10, DOI: 10.1002/cam4.6595.
Authors: Jin Liu, Shiqun Chen, Yang Zhou, Haozhang Huang, Qiang Li, Yan Liang, Shaohong Dong, Xiaoyu Huang, Liling Chen, Xueyan Zheng et al.
Conclusion
Given the researcherās strong foundation in medicine, international research exposure, active engagement in clinical cardiology, and demonstrated commitment through scholarships and fellowships, they are a strong candidate for the Best Researcher Award. While building their publication record and increasing visibility at key conferences could enhance their profile, their strengths in clinical practice, research acumen, and multilingual proficiency present them as an asset to the scientific and medical research community.